What is Relmada Therapeutics, Inc.'s current debt?

Relmada Therapeutics, Inc. (RLMD) reported current debt of $104.06M in Q2 2023.

How has Relmada Therapeutics, Inc.'s current debt changed year-over-year?

Relmada Therapeutics, Inc.'s current debt decreased by 40.4% year-over-year, from $174.69M to $104.06M.

What does current debt mean?

The portion of long-term debt maturing within the next 12 months, requiring refinancing or repayment from operating cash flows.

Relmada Therapeutics, Inc. RLMD Current Debt

Discontinued — last reported Q2 '23

Current Debt at other companies

Johnson & JohnsonJNJ

$17.46B+25.6%

ArvinasARVN

$200K0.0%

Replimune GroupREPL

$2.86M+3.0%

Nuvation BioNUVB

$5.79M+1.8%

Rigel PharmaceuticalsRIGL

$22.5M—

ImmunityBio, Inc.IBRX

——

Other financials

Income statement

See full

Operating income-$19.5M-6.8%

Net income-$19.1M-8.5%

EPS (diluted)-$0.22+62.1%

Balance sheet

See full

Cash & equivalents$9.8M+750%

Total debt$104.1M-40.4%

Total equity$218.7M+875%

Total assets$235.4M+750%

Cash flow

See full

Operating cash flow-$15.1M+16.6%

Valuation

See full

Market cap$677.17M+2,907%

Returns & leverage

See full

Return on equity-48.8%-20.0pp

Debt / equity0.9×0.0×

Current ratio18.3×+13.0×

Where this comes from

Reported directly by Relmada Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ShorttermDebtFairValue.

The official record: Relmada Therapeutics, Inc.’s 10-Q, filed August 8, 2023, on SEC EDGAR. View the filing →

Ask your AI about Relmada Therapeutics, Inc.'s current debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Relmada Therapeutics, Inc.'s current debt?: Relmada Therapeutics, Inc. (RLMD) reported current debt of $104.06M in Q2 2023.
How has Relmada Therapeutics, Inc.'s current debt changed year-over-year?: Relmada Therapeutics, Inc.'s current debt decreased by 40.4% year-over-year, from $174.69M to $104.06M.
What does current debt mean?: The portion of long-term debt maturing within the next 12 months, requiring refinancing or repayment from operating cash flows.